Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Zhou Kai
Full-time employees:6214
City:Shenyang
Address:No.8 Kunminghu Street
IPO:1996-05-23
CIK:
Website:
General Outlook
In simple terms, Northeast Pharmaceutical Group Co., Ltd. has 1429.104 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.400% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.059%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.044%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.023% return, is a testament to Northeast Pharmaceutical Group Co., Ltd.'s adeptness in optimizing resource deployment. Northeast Pharmaceutical Group Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.075%. Furthermore, the proficiency of Northeast Pharmaceutical Group Co., Ltd. in capital utilization is underscored by a remarkable 0.085% return on capital employed.
Stock Prices
Northeast Pharmaceutical Group Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4.85, while its low point bottomed out at $4.79. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Northeast Pharmaceutical Group Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing 000597.SZ liquidity ratios reveals its financial health of the firm.
The current ratio of 102.24% gauges short-term asset coverage for liabilities.
The quick ratio (86.41%) assesses immediate liquidity, while the cash ratio (59.06%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
102.24%
Quick Ratio
86.41%
Cash Ratio
59.06%
Profitability Ratios
000597.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 5.94% underscores its earnings before tax deductions.
The effective tax rate stands at 22.98%, revealing its tax efficiency.
The net income per EBT, 73.43%, and the EBT per EBIT, 101.01%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 5.88%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
5.94%
Effective Tax Rate
22.98%
Net Income per EBT
73.43%
EBT per EBIT
101.01%
EBIT per Revenue
5.88%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.02, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 314.28% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
86
Days of Inventory Outstanding
101
Operating Cycle
217.10
Days of Payables Outstanding
103
Cash Conversion Cycle
114
Receivables Turnover
3.14
Payables Turnover
3.53
Inventory Turnover
3.62
Fixed Asset Turnover
1.82
Asset Turnover
0.54
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.38, and free cash flow per share, 0.21, depict cash generation on a per-share basis.
The cash per share value, 3.95, showcases liquidity position.
A payout ratio of 0.68 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.07, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
0.38
Free Cash Flow per Share
0.21
Cash per Share
3.95
Payout Ratio
0.68
Operating Cash Flow Sales Ratio
0.07
Free Cash Flow to Operating Cash Flow Ratio
0.57
Cash Flow Coverage Ratio
0.08
Short Term Coverage Ratio
0.08
Capital Expenditure Coverage Ratio
2.30
Dividend Paid and Capex Coverage Ratio
1.13
Dividend Payout Ratio
0.03
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 45.05%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 1.38, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 6.61%, and total debt to capitalization, 57.97%, ratios shed light on its capital structure.
An interest coverage of 6.17 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
45.05%
Debt Equity Ratio
1.38
Long Term Debt to Capitalization
6.61%
Total Debt to Capitalization
57.97%
Interest Coverage
6.17
Cash Flow to Debt Ratio
0.08
Company Equity Multiplier
3.06
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 5.69, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 0.25, reflects the portion of profit attributed to each share.
The book value per share, 3.48, represents the net asset value distributed per share, while the tangible book value per share, 3.11, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
5.69
Net Income Per Share
0.25
Book Value Per Share
3.48
Tangible Book Value Per Share
3.11
Shareholders Equity Per Share
3.48
Interest Debt Per Share
4.85
Capex Per Share
-0.16
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -7.35%, indicates top-line expansion, while the gross profit growth, -8.49%, reveals profitability trends.
EBIT growth, -0.28%, and operating income growth, -0.28%, offer insights into operational profitability progression.
The net income growth, 2.34%, showcases bottom-line expansion, and the EPS growth, -3.85%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-7.35%
Gross Profit Growth
-8.49%
EBIT Growth
-0.28%
Operating Income Growth
-0.28%
Net Income Growth
2.34%
EPS Growth
-3.85%
EPS Diluted Growth
-3.85%
Weighted Average Shares Growth
6.38%
Weighted Average Shares Diluted Growth
6.38%
Dividends per Share Growth
88.75%
Operating Cash Flow Growth
-47.07%
Free Cash Flow Growth
-59.36%
10-Year Revenue Growth per Share
9.02%
5-Year Revenue Growth per Share
-8.23%
3-Year Revenue Growth per Share
-5.52%
10-Year Operating CF Growth per Share
213.89%
5-Year Operating CF Growth per Share
72.79%
3-Year Operating CF Growth per Share
-12.15%
10-Year Net Income Growth per Share
211.00%
5-Year Net Income Growth per Share
54.17%
3-Year Net Income Growth per Share
2400.00%
10-Year Shareholders Equity Growth per Share
71.55%
5-Year Shareholders Equity Growth per Share
20.66%
3-Year Shareholders Equity Growth per Share
7.12%
10-Year Dividend per Share Growth per Share
-40.17%
3-Year Dividend per Share Growth per Share
50.34%
Receivables Growth
-7.90%
Inventory Growth
11.77%
Asset Growth
10.60%
Book Value per Share Growth
2.85%
Debt Growth
209.55%
R&D Expense Growth
-46.00%
SGA Expenses Growth
7.78%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 8,960,006,917.06, captures the company's total value, considering both debt and equity.
Income quality, 1.64, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 1.06%, highlights investment in innovation.
The ratio of intangibles to total assets, 5.57%, indicates the value of non-physical assets, and capex to operating cash flow, -40.12%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
8,960,006,917.06
Income Quality
1.64
Sales General and Administrative to Revenue
0.03
Research and Development to Revenue
1.06%
Intangibles to Total Assets
5.57%
Capex to Operating Cash Flow
-40.12%
Capex to Revenue
-2.88%
Capex to Depreciation
-40.94%
Stock-Based Compensation to Revenue
1.25%
Graham Number
4.42
Return on Tangible Assets
2.49%
Graham Net Net
-1.16
Working Capital
214,572,010
Tangible Asset Value
4,465,246,600
Net Current Asset Value
-174,732,361
Invested Capital
1
Average Receivables
2,728,744,606.5
Average Payables
2,859,295,575.5
Average Inventory
1,292,253,020.5
Days Sales Outstanding
117
Days Payables Outstanding
102
Days of Inventory On Hand
99
ROIC
2.38%
ROE
0.07%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.31, and the price to book ratio, 1.31, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 0.84, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 22.44, and price to operating cash flows, 12.07, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
1.31
Price to Book Ratio
1.31
Price to Sales Ratio
0.84
Price Cash Flow Ratio
12.07
Price Earnings to Growth Ratio
-0.21
Enterprise Value Multiple
6.99
Price Fair Value
1.31
Price to Operating Cash Flow Ratio
12.07
Price to Free Cash Flows Ratio
22.44
Price to Tangible Book Ratio
1.54
Enterprise Value to Sales
1.10
Enterprise Value Over EBITDA
9.52
EV to Operating Cash Flow
15.27
Earnings Yield
4.66%
Free Cash Flow Yield
4.56%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
